Lower brain glutamate is associated with cognitive deficits in HIV patients: A new mechanism for HIV-associated neurocognitive disorder

Journal of Magnetic Resonance Imaging

Volumn 32, Issue 5, 2010, Pages 1045-1053

  Ernst, Thomas ^a   Jiang, Caroline S ^a   Nakama, Helenna ^a   Buchthal, Steven ^a   Chang, Linda ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

brain; cognition; glutamate; HIV; magnetic resonance spectroscopy (MRS)

Indexed keywords

GLUTAMIC ACID; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; AGE; AMINO ACID BRAIN LEVEL; ARTICLE; BASAL GANGLION; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE DURATION; EDUCATIONAL STATUS; FEMALE; GRAY MATTER; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; KARNOFSKY PERFORMANCE STATUS; MALE; NEUROPSYCHOLOGY; PRIORITY JOURNAL; SEX DIFFERENCE; VIRUS LOAD; WHITE MATTER;

ADULT; AIDS DEMENTIA COMPLEX; BRAIN; COGNITION DISORDERS; FEMALE; GLUTAMIC ACID; HIV INFECTIONS; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED;

EID: 78349274438     PISSN: 10531807     EISSN: 15222586     Source Type: Journal    
DOI: 10.1002/jmri.22366     Document Type: Article

References (45)

1. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology 2007; 69: 1789-1799.
2. Gray F, Adle-Biassette H, Chretien F, Lorin de la Grandmaison G, Force G, Keohane C., Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments. Clin Neuropathol 2001; 20: 146-155.
3. Kaul M, Garden G, Lipton S., Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 2001; 410: 988-994.
4. Wang Z, Trillo-Pazos G, Kim S, et al. Effects of human immunodeficiency virus type 1 on astrocyte gene expression and function: potential role in neuropathogenesis. J Neurovirol 2004; 10: 25-32.
5. Erdmann N, Zhao J, Lopez AL, et al. Glutamate production by HIV-1 infected human macrophage is blocked by the inhibition of glutaminase. J Neurochem 2007; 102: 539-549.
6. Hurd R, Sailasuta N, Srinivasan R, Vigneron DB, Pelletier D, Nelson SJ., Measurement of brain glutamate using TE-averaged PRESS at 3T. Magn Reson Med 2004; 51: 435-440.
7. Chang L, Yakupov R, Nakama H, Stokes B, Ernst T., Antiretroviral treatment is associated with increased attentional load-dependent brain activation in HIV patients. J Neuroimmune Pharmacol 2008; 3: 95-104.
8. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S., Measurement of functional activities in older adults in the community. J Gerontol 1982; 37: 323-329.
9. Karnofsky DA, Burchenal JH., The clinical evaluation of chemotherapeutic agents in cancer. In:, MacLeod C, ed. Evaluation of Chemotherapeutic Agents. New York: Columbia University Press. 1949: 199-205.
10. Provencher S., Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR Biomed 2001; 14: 260-264.
11. Ernst T, Kreis R, Ross BD., Absolute quantitation of water and metabolites in the human brain. I: compartments and water. J Magn Reson 1993; B102: 1-8.
12. Zhang Y, Brady M, Smith S., Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging 2001; 20: 45-57.
13. Woolrich MW, Jbabdi S, Patenaude B, et al. Bayesian analysis of neuroimaging data in FSL. Neuroimage 2009; 45: S173-186.
14. Chang L, Jiang CS, Ernst T., Effects of age and sex on brain glutamate and other metabolites. Magn Reson Imaging 2009; 27: 142-145.
15. Hetherington H, Mason G, Pan J, et al. Evaluation of cerebral gray and white matter metabolites differences by spectroscopic imaging at 4.1T. Magn Reson Med 1994; 32: 565-571.
16. Schuff N, Ezekiel F, Gamst AC, et al. Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging. Magn Reson Med 2001; 45: 899-907.
17. Dagan T, Sable C, Bray J, Gerschenson M., Mitochondrial dysfunction and antiretroviral nucleoside analog toxicities: what is the evidence?. Mitochondrion 2002; 1: 397-412.
18. Kohler JJ, Lewis W., A brief overview of mechanisms of mitochondrial toxicity from NRTIs. Environ Mol Mutagen 2007; 48: 166-172.
19. Sailasuta N, Shriner K, Ross B., Evidence of reduced glutamate in the frontal lobe of HIV-seropositive patients. NMR Biomed 2009; 22: 326-331.
20. Morris P, Bachelard H., Reflections on the application of 13C-MRS to research on brain metabolism. NMR Biomed 2003; 16: 303-312.
21. Shen J, Petersen KF, Behar KL, et al. Determination of the rate of the glutamate/glutamine cycle in the human brain by in vivo 13C NMR. Proc Natl Acad Sci U S A 1999; 96: 8235-8240.
22. Bell J., The neuropathology of adult HIV infection. Revue Neurol 1998; 154: 816-829.
23. Zou JY, Crews FT., TNF alpha potentiates glutamate neurotoxicity by inhibiting glutamate uptake in organotypic brain slice cultures: neuroprotection by NF kappa B inhibition. Brain Res 2005; 1034: 11-24.
24. Muscoli C, Visalli V, Colica C, et al. The effect of inflammatory stimuli on NMDA-related activation of glutamine synthase in human cultured astroglial cells. Neurosci Lett 2005; 373: 184-188.
25. Ferrarese C, Aliprandi A, Tremolizzo L, etal. Increased glutamate in CSF and plasma of patients with HIV dementia. Neurology 2001; 57: 671-675.
26. Turchan J, Sacktor N, Wojna V, Conant K, Nath A., Neuroprotective therapy for HIV dementia. Curr HIV Res 2003; 1: 373-383.
27. Pohl P, Vogl G, Fill H, Rossler H, Zangerle R, Gerstenbrand F., Single photon emission computed tomography in AIDS dementia complex. J Nucl Med 1988; 29: 1382-1386.
28. Masdeu JC, Yudd A, Van Heertun RL, et al. Single photon emission computed tomography in human immunodeficiency virus encephalopathy: a preliminary report. J Nucl Med 1991; 32: 1471-1475.
29. Holman BL, Garada B, Johnson KA, et al. A comparison of brain perfusion SPECT in cocaine abuse and AIDS dementia complex. J Nucl Med 1992; 33: 1312-1315.
30. Harris GJ, Pearlson GD, McArthur JC, Zeger S, LaFrance ND., Altered cortical blood flow in HIV-seropositive individuals with and without dementia: a single photon emission computed tomography study. AIDS 1994; 8: 495-499.
31. Schwartz RB, Komaroff AL, Garada BM, et al. SPECT imaging of the brain: comparison of findings in patients with chronic fatigue syndrome, AIDS dementia complex, and major unipolar depression. Am J Roentgenol 1994; 162: 943-951.
32. Rosci MA, Pignorini F, Bernabei A, et al. Methods for detecting early signs of AIDS dementia complex in asymptomatic subjects: a quantitative tomography study of 18 cases. AIDS 1996; 6: 1309-1316.
33. Rottenberg DA, Moeller JR, Strother SC, et al. The metabolic pathology of the AIDS dementia complex. Ann Neurol 1987; 22: 700-706.
34. Rottenberg DA, Sidtis JJ, Strother SC, etal. Abnormal cerebral glucose metabolism in HIV-1 seropositive subjects with and without dementia. J Nucl Med 1996; 37: 1133-1141.
35. Chang L, Ernst T, Leonido-Yee M, Speck O., Perfusion MRI detects rCBF abnormalities in early stages of HIV-cognitive motor complex. Neurology 2000; 54: 389-396.
36. Chang L, Ernst T, Leonido-Yee M, Walot I, Singer E., Cerebral metabolite abnormalities correlate with clinical severity of HIV-cognitive motor complex. Neurology 1999; 52: 100-108.
37. Chang L, Tomasi D, Yakupov R, et al. Adaptation of the attention network in human immunodeficiency virus brain injury. Ann Neurol 2004; 56: 259-272.
38. Stephensen CB, Marquis GS, Douglas SD, Kruzich LA, Wilson CM., Glutathione, glutathione peroxidase, and selenium status in HIV-positive and HIV-negative adolescents and young adults. Am J Clin Nutr 2007; 85: 173-181.
39. Jarvik JG, Lenkinski RE, Grossman RI, Gomori JM, Schnall MD, Frank I., Proton MR spectroscopy of HIV-infected patients: characterization of abnormalities with imaging and clinical correlation. Radiology 1993; 186: 739-744.
40. Tracey I, Carr CA, Guimaraes AR, Worth JL, Navia BA, Gonzalez RG., Brain choline-containing compounds are elevated in HIV-positive patients before the onset of AIDS dementia complex: a proton magnetic resonance spectroscopic study. Neurology 1996; 46: 783-788.
41. English C, Kaufman M, Worth J, et al. Elevated frontal lobe cytosolic choline levels in minimal or mild AIDS dementia complex patients: a proton magnetic resonance spectroscopy study. Biol Psychiatry 1997; 41: 500-502.
42. Marcus C, Taylor-Robinson S, Sargentoni J, etal. 1H MR spectroscopy of the brain in HIV-1 seropositive subjects: evidence for diffuse metabolic abnormalities. Metab Brain Disord 1998; 13: 123-136.
43. Suwanwelaa N, Phanuphak P, Phanthumchinda K, et al. Magnetic resonance spectroscopy of the brain in neurologically asymptomatic HIV-infected patients. Magn Reson Imaging 2000; 18: 859-865.
44. von Giesen H, Wittsack H, Wenserski F, Koller H, Arendt G., Basal ganglia metabolite abnormalities in minor motor disorder associated with human immunodeficiency virus type 1. Arch Neurol 2001; 58: 1281-1286.
45. Chang L, Ernst T, Witt M, etal. Relationships among cerebral metabolites, cognitive function and viral loads in antiretroviral-naàve HIV patients. NeuroImage 2002; 17: 1638-1648.